EnsoData, Aeroflow partner to increase adherence 

MADISON, Wis., and ASHEVILLE, N.C. – EnsoData and Aeroflow Health have announced a strategic partnership to use predictive clinical AI tools to enable more timely patient care, increase patient adherence and strengthen the provider-patient connection.

As part of the partnership, Aeroflow’s sleep coaches will use EnsoTherapy to provide rapid, personalized support to patients who are struggling with therapy adherence. EnsoTherapy’s task generation and smart-prioritization allow for more streamlined and logical patient-coach pairings and assignments, leading to improved patient compliance, the companies say.

"Our PAP therapy prediction models accurately predict 30-, 60-, and 90-day patient compliance within days of starting treatment," said Sam Rusk, EnsoData chief artificial intelligence officer. “EnsoTherapy will have a transformative impact on the growing patient population who face challenges in treating their sleep apnea, by enabling Aeroflow to better prioritize the patients in their network who struggle the most on therapy and have the greatest potential health and adherence benefit from targeted coaching and intervention. This collaboration will bring patients the best CPAP therapy onboarding experience possible and help them feel understood throughout their treatment journey, while also demonstrating best-in-class adherence results. This is a true win-win for patients and for providers alike.”

EnsoData’s sleep coach Lacey Adams, RPSGT, CCSH, provided support and mentorship to Aeroflow’s sleep coaches for a fast onboarding process.

EnsoData also has a partnership with React Health to integrate its AI technology into the company’s Connect patient management software platform. 

• Listen up: EnsoData’s Justin Mortara was a recent guest on the HME news in 10 podcast to talk about AI-powered CPAP therapy.